David C. U’Prichard

4.2k total citations · 1 hit paper
43 papers, 3.5k citations indexed

About

David C. U’Prichard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Animal Science and Zoology. According to data from OpenAlex, David C. U’Prichard has authored 43 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 4 papers in Animal Science and Zoology. Recurrent topics in David C. U’Prichard's work include Receptor Mechanisms and Signaling (30 papers), Neuroscience and Neuropharmacology Research (20 papers) and Neuropeptides and Animal Physiology (12 papers). David C. U’Prichard is often cited by papers focused on Receptor Mechanisms and Signaling (30 papers), Neuroscience and Neuropharmacology Research (20 papers) and Neuropeptides and Animal Physiology (12 papers). David C. U’Prichard collaborates with scholars based in United States, Canada and Sweden. David C. U’Prichard's co-authors include Solomon H. Snyder, David A. Greenberg, S.J. Enna, Adriana Maggi, Bruce D. Perry, David B. Bylund, Jon M. Stolk, B. Rouot, Makoto Daiguji and Herbert Y. Meltzer and has published in prestigious journals such as Nature, Science and Genetics.

In The Last Decade

David C. U’Prichard

42 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Binding Characteristics of a Radiolabeled Agonist and Antagonist at Central Nervous System Alpha Noradrenergic Receptors

1977 474 citations David C. U’Prichard, David A. Greenberg et al. Molecular Pharmacology profile →

Peers

Countries citing papers authored by David C. U’Prichard

Since Specialization

Citations

This map shows the geographic impact of David C. U’Prichard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. U’Prichard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. U’Prichard more than expected).

Fields of papers citing papers by David C. U’Prichard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. U’Prichard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. U’Prichard. The network helps show where David C. U’Prichard may publish in the future.

Co-authorship network of co-authors of David C. U’Prichard

This figure shows the co-authorship network connecting the top 25 collaborators of David C. U’Prichard. A scholar is included among the top collaborators of David C. U’Prichard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. U’Prichard. David C. U’Prichard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corporate Strategy: The Future of Drug Industry Research and the Zeneca Response 1997 ·Research-Technology Management ·David C. U’Prichard, Linda M. Pullan	2
2	Epinephrine in the central nervous system 1988 ·Oxford University Press eBooks ·Jon M. Stolk, David C. U’Prichard, Kjell Fuxé	91
3	Modulation of agonist and antagonist interactions at kidney α1-adrenoceptors by nucleotides and metal ions 1987 ·European Journal of Pharmacology ·Paul Ernsberger, David C. U’Prichard	13
4	INHERITANCE OF ADRENAL PHENYLETHANOLAMINE N-METHYLTRANSFERASE ACTIVITY IN THE RAT 1984 ·Genetics ·Jon M. Stolk, G. Vantini, Ras B. Guchhait, (unknown), Bruce D. Perry, David C. U’Prichard, Robert C. Elston	4
5	Biochemical Characteristics and Regulation of Brain α₂‐Adrenoceptors^a 1984 ·Annals of the New York Academy of Sciences ·David C. U’Prichard	32
6	Binding of the imidazoline UK-14, 304, a putative full α2-adrenoceptor agonist, to rat cerebral cortex membranes 1984 ·Life Sciences ·Douglas J. Loftus, Jon M. Stolk, David C. U’Prichard	37
7	Characterization of α1-and α2-Adrenergic Receptors 1983 ·International review of neurobiology ·David B. Bylund, David C. U’Prichard	188
8	Molecular size of the human platelet alpha2-adrenergic receptor as determined by radiation inactivation 1983 ·Biochemical and Biophysical Research Communications ·J. Craig Venter, (unknown), David C. U’Prichard, Claire M. Fraser	27
9	The variety of vascular α-adrenoceptor 1983 ·Trends in Pharmacological Sciences ·David C. U’Prichard	2
10	[3H]rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptors 1981 ·European Journal of Pharmacology ·Bruce D. Perry, David C. U’Prichard	159
11	Multiple α₂‐Noradrenergic Receptor Sites in Rat Brain: Selective Regulation of High‐Affinity [³H] Clonidine Binding by Guanine Nucleotides and Divalent Cations 1980 ·Journal of Neurochemistry ·(unknown), David C. U’Prichard, Solomon H. Snyder	110
12	1α,25-Dihydroxyvitamin D ₃ Nuclear Receptors in Pituitary 1980 ·Science ·Harris A. Gelbard, Paula H. Stern, David C. U’Prichard	23
13	Differential supersensitivity of β-receptor subtypes in rat cortex and cerebellum after central noradrenergic denervation 1980 ·Life Sciences ·David C. U’Prichard, Terry Reisine, (unknown), Stephen T. Mason, H.C. Fibiger, (unknown), Henry I. Yamamura	34
14	Multiple Apparent Alpha-Noradrenergic Receptor Binding Sites in Rat Brain: Effect of 6-Hydroxydopamine 1979 ·Molecular Pharmacology ·David C. U’Prichard, (unknown), B. Rouot, Solomon H. Snyder	211
15	[3H]Clonidine binding to two α-adrenergic sites in rat CNS: Differential effects of 6-hydroxydopamine 1979 ·David C. U’Prichard, Solomon H. Snyder	2
16	α-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists 1978 ·Brain Research ·David A. Greenberg, David C. U’Prichard, (unknown), Solomon H. Snyder	73
17	Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites 1978 ·European Journal of Pharmacology ·David C. U’Prichard, Michael E. Charness, David L. Robertson, Solomon H. Snyder	116
18	Regional Variations in Alpha Adrenergic Receptor Interactions of [3H]-Dihydroergokryptine in Calf Brain: Implications for a Two-Site Model of Alpha Receptor Function 1978 ·Molecular Pharmacology ·Stephen J. Peroutka, David A. Greenberg, David C. U’Prichard, Solomon H. Snyder	43
19	Catecholamine binding to CNS adrenergic receptors 1978 ·Journal of Supramolecular Structure ·David C. U’Prichard, Solomon H. Snyder	8
20	Binding Characteristics of a Radiolabeled Agonist and Antagonist at Central Nervous System Alpha Noradrenergic Receptors breakdown → 1977 ·Molecular Pharmacology ·David C. U’Prichard, David A. Greenberg, Solomon H. Snyder	474

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact